Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Assess the effect of a high-fat meal on the in vivo performance of Raltegravir/lamivudine (MK-0518B) 300 mg/150 mg Fixed-Dose Combination (FDC) tablets from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., USA after a single-dose in healthy subjects.
Inclusion criteria
- N/A